A new scoping review published in Conflict and Health has mapped the specific implementation barriers and coverage outcomes for the two primary polio vaccines used in humanitarian emergencies. The study, conducted by researchers including Jai Singh, Adam C. Levine, and Malabika Sarker, aims to inform vaccine selection strategies in disaster settings where global eradication efforts face significant logistical and sociopolitical hurdles. As the Global Polio Eradication Initiative targets the complete elimination of polio by 2029, understanding the distinct delivery requirements of Inactivated Polio Vaccine (IPV) and Oral Polio Vaccine (OPV) is critical for operational planning in unstable regions.
The research team followed the PRISMA extension for Scoping Reviews (PRISMA-ScR) to conduct a comprehensive search of major databases, including PubMed, EMBASE, Web of Science, and the Cochrane Library. The inclusion criteria required studies to focus on OPV and/or IPV campaigns in humanitarian crises, provide data on coverage or logistics, and be published in English within the last 20 years.
From an initial pool of 1,604 identified studies, only 24 met the strict inclusion criteria for the final analysis. The review found that IPV faces distinct operational challenges, primarily driven by higher operational costs and the requirement for skilled health workers.
In contrast, the barriers associated with OPV are largely sociopolitical and security-related. Prominent obstacles included bans on vaccination campaigns by armed groups and widespread misinformation that leads to community vaccine refusal. Despite these challenges, the review noted that OPV campaigns frequently achieved high coverage rates, with fourteen studies reporting that coverage often exceeded 90%, particularly when supported by effective partnerships and robust social mobilization efforts.
The review also examined coverage outcomes for IPV, finding that three studies reported high coverage rates ranging from 80% to 102.9%. These successful IPV campaigns were characterized by their delivery alongside OPV and strong community engagement. However, the evidence base for IPV is significantly smaller than that for OPV, with only three studies providing effectiveness data compared to fourteen for OPV.
The authors conclude that OPV emerges as the more practical mainstay for large-scale campaigns in crisis settings due to its lower cost and ease of administration. Nevertheless, they emphasize three critical caveats to this conclusion. First, the evidence base is asymmetric, with far fewer studies on IPV. Second, the outcome measured was administrative coverage rather than seroconversion or the actual interruption of transmission. Third, several OPV campaigns that reported high coverage were themselves responses to circulating vaccine-derived poliovirus, which complicates the interpretation of their success in general eradication efforts.
Despite the logistical, operational, and cost barriers limiting its scalability in emergencies, IPV remains essential to the final stages of polio eradication. The review underscores that regardless of the delivery method, effective partnerships and community engagement are critical to campaign success. The authors identify a significant knowledge gap regarding IPV-only immunization campaigns in crisis settings, indicating a need for further research to guide future implementation strategies in disaster areas.
This scoping review provides policymakers and operational actors with an evidence base to inform decisions on future implementation strategies in humanitarian contexts. By distinguishing between the logistical hurdles of IPV and the security challenges of OPV, the study offers a nuanced view of vaccine delivery in complex emergencies.
Subject of Research: Implementation barriers and coverage outcomes of polio vaccines in humanitarian settings
Article Title: Barriers & coverage outcomes of inactivated polio vaccine & oral polio vaccine in humanitarian settings: a scoping review
Article References: Singh, J., Levine, A. C., & Sarker, M. (2026). Barriers & coverage outcomes of inactivated polio vaccine & oral polio vaccine in humanitarian settings: a scoping review. Conflict and Health. https://doi.org/10.1186/s13031-026-00833-x
Image Credits: AI Generated
DOI: 10.1186/s13031-026-00833-x
Keywords: polio eradication, humanitarian settings, IPV, OPV, scoping review, vaccine coverage, Conflict and Health, implementation barriers, global health, emergency response, Barriers, coverage
News Source: Kristina Jarvis. (November 8, 2026). Scoping Review Maps Polio Vaccine Barriers in Crises. Scienmag.



